We are delighted to honor this year’s exceptional early-career Chinese cancer researchers for their significant achievements in advancing cancer research and drug development.
Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA–AFCR Young Investigator Award to recognize and support promising scientists at the forefront of U.S.–China collaboration. These awardees are already translating groundbreaking laboratory discoveries into innovative treatments that hold hope for patients worldwide.
2025 Awardees
-
Zhenhua Chen, Ph.D. – Principal Investigator, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine.
-
Chen Zhao, M.D., Ph.D. – Postdoctoral Researcher, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles.
👏 Join us in congratulating the 2025 awardees as they continue to pave the way toward a future free of cancer! To learn more about the Award and past recipients, please click here.
